| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 04/06/2011 | CN101569634B 抗老化剂 Anti-aging agents |
| 04/06/2011 | CN101406489B Method of preparing micro-ecological complex bacterial agent |
| 04/06/2011 | CN101259122B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/06/2011 | CN101259121B Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 04/05/2011 | US7919612 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents |
| 04/05/2011 | US7919524 Compounds, compositions and methods |
| 04/05/2011 | US7919513 Inhibitors of p38 |
| 04/05/2011 | US7919507 N-aroyl cyclic amines |
| 04/05/2011 | US7919479 Antiadhesive carbohydrates |
| 04/05/2011 | US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 04/05/2011 | US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor |
| 04/05/2011 | US7919329 Method for screening for agents that affect food intake |
| 04/05/2011 | US7919311 Compositions and methods for activating genes of interest |
| 04/05/2011 | US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 04/05/2011 | US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL) |
| 04/05/2011 | CA2494695C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/05/2011 | CA2475434C Aromatic amino acid derivatives and medicinal compositions |
| 04/05/2011 | CA2475432C 2,4,6-triamino-1,3,5-triazine derivative |
| 04/05/2011 | CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity |
| 04/05/2011 | CA2463348C Use of hydroxyoleic acid and related compounds in the manufacture of drugs |
| 04/05/2011 | CA2447909C Use of proteasome inhibitors to treat dry eye disorders |
| 04/05/2011 | CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance |
| 04/05/2011 | CA2408747C Heterocyclic inhibitors of glycogen synthase kinase gsk-3 |
| 04/05/2011 | CA2330916C Triterpene compositions and methods for use thereof |
| 03/31/2011 | WO2011037271A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/31/2011 | WO2011037252A1 Liposome preparation containing spicamycin derivative |
| 03/31/2011 | WO2011037223A1 Agent for reducing visceral fat weight |
| 03/31/2011 | WO2011037192A1 Substituted amide compound |
| 03/31/2011 | WO2011037160A1 Antibody capable of recognizing hla class i |
| 03/31/2011 | WO2011036895A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | WO2011036889A1 Heterocyclic compound |
| 03/31/2011 | WO2011036885A1 Heterocyclic compound |
| 03/31/2011 | WO2011036786A1 Stress-alleviating agent comprising plant-derived polyamine-containing extract as active ingredient |
| 03/31/2011 | WO2011035500A1 Use of piperphentonamine or salts thereof in manufacture of medicaments for preventing / treating brain diseases |
| 03/31/2011 | WO2010118330A3 Use of tetrahydrobiopterin as a marker and a therapeutic agent for fabry disease |
| 03/31/2011 | WO2010083328A3 Methods for screening and compounds that protect against amyloid diseases |
| 03/31/2011 | US20110077289 Method of treating pneumoconiosis with oligodeoxynucleotides |
| 03/31/2011 | US20110077286 Oligonucleotide duplexes comprising dna-like and rna-like nucleotides and uses thereof |
| 03/31/2011 | US20110077208 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 03/31/2011 | US20110076765 Method for increasing the activity of lysosomal enzymes |
| 03/31/2011 | US20110076344 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response |
| 03/31/2011 | US20110076341 Trace elements |
| 03/31/2011 | US20110076316 Scalable matrix for the in vivo cultivation of bone and cartilage |
| 03/31/2011 | US20110076307 Polycationic gene carriers formed of endogenous amino group-bearing monomers |
| 03/31/2011 | US20110076295 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases |
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | US20110076275 Method of Modifying Isoelectric Point of Antibody Via Amino Acid Substitution in CDR |
| 03/31/2011 | US20110076246 Thiol-containing compounds for the removal of elements from contaminated milieu and methods of use |
| 03/31/2011 | US20110076239 Reduced-sweetener products, flavoring mixtures for said reduced-sweetener products and process for the production of products of this type |
| 03/31/2011 | CA2775027A1 Maleic acid salt and crystal thereof |
| 03/31/2011 | CA2774647A1 Substituted amide compound |
| 03/31/2011 | CA2772230A1 Humanized antibodies specific for amino acid sequence rgd of an extracellular matrix protein and the uses thereof |
| 03/30/2011 | EP2302391A1 Therapeutic and diagnostic uses of antibody specificity profiles in rheumatoid arthritis |
| 03/30/2011 | EP2302387A1 Therapeutic and diagnostic uses of antibody specificity profiles for insulin-dependent diabetes mellitus |
| 03/30/2011 | EP2301971A1 Antibodies that bind both BCMA and TACI |
| 03/30/2011 | EP2301970A1 Human antibodies that bind human IL-12 and methods for producing |
| 03/30/2011 | EP2301952A2 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 03/30/2011 | EP2301936A1 Spirodiamine-diarylketoxime derivative |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301922A1 Pyridone compound |
| 03/30/2011 | EP2301582A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/30/2011 | EP2301579A1 Therapeutic method for reducing angiogenesis |
| 03/30/2011 | EP2301578A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301577A2 Methods for treating TWEAK-related conditions |
| 03/30/2011 | EP2301565A1 Use of proteasome inhibitors for the treatment of viral infections |
| 03/30/2011 | EP2301560A1 Pharmaceutical agent for promoting the functional regeneration of damaged tissue |
| 03/30/2011 | EP2301559A1 Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation |
| 03/30/2011 | EP2301534A1 Amino-methyl substituted tetracycline compounds |
| 03/30/2011 | EP2300014A1 Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis |
| 03/30/2011 | EP2299815A1 Method of treating burns using avermectin compound |
| 03/30/2011 | EP1843789B1 Compositions and methods for treating fibrotic disorders |
| 03/30/2011 | EP1775289B1 Novel imidazolidine derivatives |
| 03/30/2011 | EP1355658B1 Anti HER3 antibody for diagnosis, prevention and treatment of hyperproliferative diseases |
| 03/30/2011 | EP1317485B1 Myostatin antagonists and uses thereof |
| 03/30/2011 | EP1305007B1 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN1489583B Novel physiologically active substance |
| 03/30/2011 | CN101998998A Aminosugar compound and process for production thereof |
| 03/30/2011 | CN101998854A Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cycklopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| 03/30/2011 | CN101991797A Medicine formula for treating Behcet's disease |
| 03/30/2011 | CN101991790A Medicine for treating pseudodiabetes |
| 03/30/2011 | CN101991769A Traditional Chinese medicine composition for treating heart-kidney imbalance |
| 03/30/2011 | CN101991733A Application of agastache rugosus extract in preparing drug for lowering viscera sensitivity |
| 03/30/2011 | CN101991711A Traditional Chinese medicine composition for viscera fire syndrome and preparation method thereof |
| 03/30/2011 | CN101991607A Traditional Chinese medicinal composition for treating spontaneous sweating and night sweat and preparation method thereof |
| 03/30/2011 | CN101991589A Glycerol fructose injection and preparation method thereof |
| 03/30/2011 | CN101991568A Application of senkyunolide I in preparation of antidepressant medicament, migraine medicament and medicaments for other diseases relevant to 5-hydroxytryptamine system |
| 03/30/2011 | CN101991105A Food medicine |
| 03/30/2011 | CN101375839B Grifola frondosa polysaccharide soft capsules and preparation method thereof |
| 03/30/2011 | CN101327203B Gallic acid chelates composition and uses thereof |
| 03/30/2011 | CN101309746B Method for production of single- and multi-layer microcapsules |
| 03/30/2011 | CN101111508B Spiroketal derivative and use thereof as diabetic medicine |
| 03/30/2011 | CN101077152B Pearl facial-nourishing bean product and its manufacturing method |
| 03/30/2011 | CN101007790B Oxamic acid derivative, and its preparation method and medicinal uses |
| 03/29/2011 | US7915400 RNA interference mediated inhibition of hepatitis C virus (HCV) gene expression using short interfering nucleic acid (siNA) |
| 03/29/2011 | US7915307 Methods of improving the pharmacokinetics of doxepin |
| 03/29/2011 | US7915291 Hepatitis C virus inhibitors |
| 03/29/2011 | US7915280 Compounds and their uses |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915265 Combinations for the treatment of immunoinflammatory disorders |